| Followers | 206 |
| Posts | 17555 |
| Boards Moderated | 3 |
| Alias Born | 03/08/2009 |
Tuesday, November 16, 2021 1:49:01 PM
.13 up! but most importantly is that the bidders have moved up slightly
Recent OTLC News
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages • InvestorsHub NewsWire • 04/09/2026 01:00:00 PM
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages • GlobeNewswire Inc. • 04/09/2026 12:30:00 PM
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Operates at Intersection of Life Sciences, Advanced Digital Technologies, • GlobeNewswire Inc. • 04/08/2026 12:30:00 PM
- AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards • InvestorsHub NewsWire • 04/07/2026 01:19:20 PM
- AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Shares Rise as Biotech Pivots Toward AI-Driven Pharmaceutical Automation • AllPennyStocks.com • 04/02/2026 05:08:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:15:10 PM
- Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform • GlobeNewswire Inc. • 04/02/2026 12:30:00 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:15:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 01:15:35 PM
- Sapu Nano to Launch Deciparticle™ Platform and Present Clinical Pipeline at BIO-Europe Spring 2026 • GlobeNewswire Inc. • 03/24/2026 12:00:00 PM
- Sapu Nano to Present Everolimus Toxicology Data at SOT 2026 Annual Meeting • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- NetworkNews Audio Announces Audio Press Release (APR) Discussing Growing Investor Attention on Companies Holding Clinical-Stage Portfolios • GlobeNewswire Inc. • 02/23/2026 01:30:00 PM
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development • InvestorsHub NewsWire • 02/19/2026 02:00:00 PM
- Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development • GlobeNewswire Inc. • 02/19/2026 01:30:00 PM
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • InvestorsHub NewsWire • 02/17/2026 02:00:00 PM
- Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway • GlobeNewswire Inc. • 02/12/2026 01:30:00 PM
- Oncotelic Therapeutics, Inc. Showcases Multi-Year Execution and Validation, Enters 2026 with Late-Stage Momentum Across Diversified Pipeline • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 09:30:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 10:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2026 09:30:40 PM
